Arovella Therapeutics Ltd has released a press release.
Arovella SPP Closed early over subscribed
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Investor Presentation
- SPP Offer Booklet
- Arovella Completes $4.57M Placement & Launches $1.5M SPP
- AGM FY21 Presentation
- Arovella licences novel monoclonal antibody from MD Anderson
Later from Arovella Therapeutics
- Update - Proposed issue of securities - ALA
- Application for quotation of securities - ALA
- Arovella Therapeutics: Proposed issue of securities - ALA
- Anagrelide patent for the United States
- Services Agreement with Q-Gen for CAR19-iNKT manufacture
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics